Headquartered in California, Amgen (Applied Molecular Genetics) is an Multinational Biopharmaceutical company which was known as Applied Molecular Genetics. Founded in 1980 It is the world’s largest independent biotechnology firm. Amgen (Applied Molecular Genetics) leverages its biologic manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives.

The company is focused on diseases like cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses and has presences in over 75 countries. Company’s largest selling product lines Neulasta/Neupogen, two closely related drugs used to prevent infections in patients undergoing cancer chemotherapy; and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases. These medicines have helped over 1 million people in their fight against cancer.

Product Portfolio:

  • Epogen
  • Aranesp
  • Sensipar/Mimpara
  • Nplate
  • Vectibix
  • Prolia
Company Information
Type Public company
Traded as NASDAQ: AMGN
Industry Biotechnology
Founded 1980
Founder NA
Headquarters Thousand Oaks, California, U.S.
Key people Robert A. Bradway (President and CEO)
Products Epogen, Aranesp, Kineret, Enbrel, Neulasta, Neupogen, Nplate, Vectibix, Prolia, Xgeva and Sensipar/Mimpara
Revenue US$ 20.063 billion (2014)
Net income US$ 5.158 billion (2014)
Number of employees 17,900 (December 2014)
Subsidiaries NA

Check Also

Valeant Pharmaceuticals

Valeant Pharmaceuticals is a publicly traded pharmaceutical company based in Montreal, Canada. The company has …